SOST and chronic kidney disease: Liao et al. [71] showed in animal experiments that, after eight weeks of endurance running, the serum concentrations of SOST and CTX-1 in CKD rats were significantly decreased, while the activity of Wnt/β-catenin, an osteogenic signaling pathway inhibited by SOST, was significantly increased.